Tumor regression by means of magnetic drug targeting.

The expression 'magnetic drug targeting' is understood as meaning the targeted administration of a drug, for example, a cytostatic, with the intention of optimizing the local therapeutic effect. A magnetic field strength of 0.6 T is applied externally to the body. Iron oxides are administered intravasally into a vein. Cytostatics are bonded to the iron oxides. This form of administration, also known as sluicing, is particularly suitable for cytostatics, since the intention is to achieve a high concentration of the cytostatic at the target site (site of the tumor), but to minimize the harmful effect in the rest of the tissue. A reduction in tumor volume under the magnetic field and in the liver of 45-90% has been detected by MRI.

[1]  M. Ibarra,et al.  Magnetic nanoparticles for local drug delivery using magnetic implants. , 2009, Methods in molecular biology.

[2]  R. Campbell,et al.  External magnet improves antitumor effect of vinblastine and the suppression of metastasis , 2009, Cancer science.

[3]  C Alexiou,et al.  Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.

[4]  C Alexiou,et al.  [Magnetic Drug Targeting--a new approach in locoregional tumor therapy with chemotherapeutic agents. Experimental animal studies]. , 2005, HNO.

[5]  Carl K. Hoh,et al.  Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy , 1999 .

[6]  J. Heckman,et al.  Pulsed Electromagnetic Fields Increase Growth Factor Release by Nonunion Cells , 2001, Clinical orthopaedics and related research.

[7]  D. Huhn,et al.  Preclinical experiences with magnetic drug targeting: tolerance and efficacy. , 1996, Cancer research.

[8]  J. Koda,et al.  Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Tsuneo Imai,et al.  Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes , 2009, Breast Cancer Research and Treatment.

[10]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[11]  Binsheng Zhao,et al.  Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. , 2009, Radiology.

[12]  C. Alexiou,et al.  Locoregional cancer treatment with magnetic drug targeting. , 2000, Cancer research.

[13]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[14]  Gabriel A Silva,et al.  Introduction to nanotechnology and its applications to medicine. , 2004, Surgical neurology.

[15]  H. Honda,et al.  Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone , 2008, The Prostate.

[16]  R K Jain,et al.  Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[17]  C. Bergemann,et al.  Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications , 1999 .

[18]  R. Müller,et al.  Drug delivery to the brain--realization by novel drug carriers. , 2004, Journal of nanoscience and nanotechnology.

[19]  C. Alexiou,et al.  Medical applications of magnetic nanoparticles. , 2006, Journal of nanoscience and nanotechnology.

[20]  C. Marquina,et al.  Magnetic nanoparticles for local drug delivery using magnetic implants , 2007 .